Brief: Immuneonco Biopharmaceuticals Shanghai Says CEO Purchased 150,000 H Shares Of Co
26/03/2025 15:02
March 26 (Reuters) - ImmuneOnco Biopharmaceuticals Shanghai Inc 1541.HK: CEO PURCHASED A TOTAL OF 150,000 H SHARES OF CO AT AN AVERAGE PRICE OF HK$5.278 PER SHARE Further company coverage: 1541.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on ImmuneOnco Biopharmaceuticals (Shanghai)
See all newsBrief: Immuneonco Biopharmaceuticals (Shanghai) To Subscribe For Wealth Management Product For Hk$87.5 Million
Brief: ImmuneOnCo Biopharmaceuticals (Shanghai) To Repurchase H Shares In Open Market
Brief: Immuneonco Biopharmaceuticals (Shanghai)Subscribes For Hk$212 Million Wealth Management Product
Brief: Immuneonco Biopharmaceuticals Shanghai Inc Posts FY Loss Attributable RMB218.6 Million
Brief: ImmuneOnco Biopharmaceuticals Shanghai Receives Approval From NMPA China For Investigational New Drug Application Of IMM0306S